Literature DB >> 14978082

IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.

Jun Chang1, Jae-Ho Cho, Seung-Woo Lee, So-Young Choi, Sang-Jun Ha, Young-Chul Sung.   

Abstract

Antigenic and costimulatory signals trigger a developmental program by which naive CD8 T cells differentiate into effector and memory cells. However, initial cytokine signals that regulate the generation of effector and memory CD8 T cells are not well understood. In this study, we show that IL-12 priming during in vitro antigenic stimulation results in the significant increase of both primary and memory CD8 T cell population in mice after adoptive transfer of activated cells. The effect of IL-12 priming is closely associated with qualitative changes in CD8 T cells, such as reduced MHC I tetramer binding and CD69 expression, altered distribution of lipid rafts, decreased cytolytic activity, and less susceptibility to apoptosis. Furthermore, exogenous IL-12 priming improved the intrinsic survival properties of memory CD8 T cells, leading to better protective immunity and vaccine-induced memory CD8 T cell responses. However, the experiments with IL-12p40- and IL-12Rbeta1-deficient mice showed similar levels of primary and memory CD8 T cell responses compared with wild-type mice, implying that endogenous IL-12 and/or IL-12R signaling in vivo is not critical for CD8 T cell immunity. Together, our results suggest that IL-12 can serve as an important, but dispensable regulatory factor for the development of CD8 T cells, and IL-12 priming could be useful in many medical applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978082     DOI: 10.4049/jimmunol.172.5.2818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Antigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses.

Authors:  Qingsheng Li; Cheryl Eppolito; Kunle Odunsi; Protul A Shrikant
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

2.  Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.

Authors:  Rūta Veinalde; Christian Grossardt; Laura Hartmann; Marie-Claude Bourgeois-Daigneault; John C Bell; Dirk Jäger; Christof von Kalle; Guy Ungerechts; Christine E Engeland
Journal:  Oncoimmunology       Date:  2017-01-31       Impact factor: 8.110

3.  Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Authors:  Mark P Rubinstein; Colleen A Cloud; Tracy E Garrett; Caitlin J Moore; Kristina M Schwartz; C Bryce Johnson; David H Craig; Mohamed L Salem; Chrystal M Paulos; David J Cole
Journal:  J Am Coll Surg       Date:  2012-02-22       Impact factor: 6.113

4.  The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.

Authors:  Curtis J Henry; Jason M Grayson; Kristina L Brzoza-Lewis; Latoya M Mitchell; Marlena M Westcott; Anne S Cook; Elizabeth M Hiltbold
Journal:  Cell Immunol       Date:  2010-04-24       Impact factor: 4.868

5.  Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates.

Authors:  Hilario J Ramos; Ann M Davis; Alexander G Cole; John D Schatzle; James Forman; J David Farrar
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

6.  IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.

Authors:  Curtis J Henry; David A Ornelles; Latoya M Mitchell; Kristina L Brzoza-Lewis; Elizabeth M Hiltbold
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  CD43 Expression Regulated by IL-12 Signaling Is Associated with Survival of CD8 T Cells.

Authors:  Jee-Boong Lee; Jun Chang
Journal:  Immune Netw       Date:  2010-10-31       Impact factor: 6.303

8.  Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.

Authors:  M P Rubinstein; M L Salem; A N Kadima; C L Nguyen; W E Gillanders; M I Nishimura; D J Cole
Journal:  Cancer Gene Ther       Date:  2008-08-08       Impact factor: 5.987

Review 9.  Blimp-1 connects the intrinsic and extrinsic regulation of T cell homeostasis.

Authors:  Stephen L Nutt; Axel Kallies; Gabrielle T Belz
Journal:  J Clin Immunol       Date:  2007-12-11       Impact factor: 8.317

10.  Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.

Authors:  S Guo; J Xu; W Denning; Z Hel
Journal:  Gene Ther       Date:  2009-07-30       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.